Growth axis research peptides, shipped within Canada.
Growth-axis research pairs a GHRH analog with a secretagogue: the analog raises the amplitude of a GH pulse, the secretagogue triggers it. CJC-1295 No DAC and ipamorelin are the classic pairing; tesamorelin is the stabilised GHRH analog with the largest clinical literature.
Growth axis peptides we stock
Questions researchers ask
- Why are CJC-1295 and ipamorelin studied together?
- They act on different receptors in the same axis. CJC-1295 is a GHRH analog acting on the GHRH receptor; ipamorelin is a ghrelin-receptor agonist. Used together in the literature, the combination produces a larger GH pulse than either alone.
- What does No DAC mean?
- No drug-affinity complex. The DAC version binds albumin for a multi-day half-life; the No DAC version is the short-acting form, closer to native GHRH kinetics, which is what most pulse studies use.
- How is tesamorelin different?
- It is a 44-amino-acid GHRH analog with an N-terminal modification for stability, and the only compound in this group with a large body of published human pharmacokinetic data.
For laboratory research use only. Not approved by Health Canada for human or veterinary use.